HKEX Insider Activity β 2026-09-08
ππ° HKEX DI Report β 2026-09-08
π NEW ENTRY β 9909 Powerlong Commercial Management β Kalson Hoi, bought 160,725,000 shares @ HKD 2.245 for HK$360.83M total (now 25.00%)
Read: A single-day HK$361m insider stake-build to a quarter of the company is a rare, high-conviction control move worth watching closely.
π NEW ENTRY β 9909 Powerlong Commercial Management β Prime Capital Holdings, bought 160,725,000 shares @ HKD 2.245 for HK$360.83M total (now 25.00%)
Read: Same stake, same numbers as the Kalson Hoi filing β this is the holding-company layer of the same 25% control block, not a separate buyer.
π NEW ENTRY β 9909 Powerlong Commercial Management β Prime Capital Investment, bought 160,725,000 shares @ HKD 2.245 for HK$360.83M total (now 25.00%)
Read: Third leg of the same ownership chain disclosing the identical 25% position β treat all three 9909 filings as one HK$361m concert-party entry.
π NEW ENTRY β 727 Sinopros Corporation β Jessie Ngai, bought 243,975,069 shares @ HKD 0.66 for HK$161.02M total (now 19.18%)
Read: A HK$161m stake surfacing at nearly a fifth of the company in one filing signals a serious strategic buyer, not a passive fund.
π NEW ENTRY β 2592 Cloudbreak Pharma β Hung Ka Kung, bought 70,519,426 shares @ HKD 1.00 for HK$70.52M total (now 10.57%)
Read: A HK$70.5m personal purchase crossing 10% is a strong insider-confidence signal in a small-cap biotech name.
π NEW ENTRY β 2592 Cloudbreak Pharma β Wealth Strategy Holding, bought 70,519,426 shares @ HKD 1.00 for HK$70.52M total (now 10.57%)
Read: Mirror filing of the Kung Hung Ka stake through his holding vehicle β same HK$70.5m position, not incremental buying.
π NEW ENTRY β 1566 CA Cultural Technology Group β Xia Fang, curr 6.65% (increased by 6.65pp from prior filing)
Read: This is a related-entity reshuffle, not open-market buying β a connected holder's disclosure lapsed (reason 1004) and the shares rolled into Xia Fang's aggregate, which now crosses 5%.
π NEW ENTRY β 1566 CA Cultural Technology Group β Li Ding, curr 6.24% (increased by 6.24pp from prior filing)
Read: Same-day companion filing to Xia Fang's β another consolidated stake crossing 5% via a lapsed related-entity disclosure rather than fresh purchases.
π NEW ENTRY β 8200 Sau San Tong Holdings β Fei Ying Kwan, bought 2,792,677 shares @ HKD 0.78 for HK$2.18M total (now 3.54%)
Read: A small HK$2.2m stake-build in a micro-cap that hasn't even cleared 5% yet β modest size, but worth flagging if buying continues.
π NEW ENTRY β 902 Huaneng Power International β JPMorgan, curr 5.21% (increased by 0.81pp from prior filing)
Read: ~HK$211m notional rolled into JPMorgan's aggregate as an affiliate's holding lapsed β a consolidation crossing 5%, not a directional bet.
π NEW ENTRY β 902 Huaneng Power International β BlackRock, curr 5.15% (increased by 0.28pp from prior filing)
Read: Index-fund entity consolidation pushing BlackRock's aggregate just past 5% β bookkeeping, not conviction buying.
π NEW ENTRY β 3908 CICC (H Shares) β BlackRock, curr 5.24% (increased by 0.27pp from prior filing)
Read: Same pattern β a related BlackRock vehicle's stake lapsed and rolled into this entity, crossing 5% mechanically rather than through fresh purchases.
π NEW ENTRY β 1398 ICBC (H Shares) β BlackRock, curr 5.07% (increased by 0.13pp from prior filing)
Read: Barely-there crossing (5.07%) from an internal entity rollup β low signal value for a mega-cap bank like ICBC.
π NEW ENTRY β 780 Tongcheng Travel β BlackRock, curr 5.01% (increased by 0.07pp from prior filing)
Read: Just scraping past the 5% disclosure line via aggregation β could easily dip back below on any minor rebalancing.
π NEW ENTRY β 358 Jiangxi Copper (H Shares) β BlackRock, curr 5.03% (increased by 0.05pp from prior filing)
Read: Smallest of the BlackRock rollups, barely clearing 5% β essentially noise-level and not indicative of active accumulation.
π’ BUYBACK β 1276 Hengrui Pharmaceuticals (H Shares) β BlackRock, curr 6.27% (decreased by 1.28pp from prior filing)
Read: The issuer's buyback program is reshaping the float and shifting BlackRock's disclosed stake β a mechanical effect, not a sale signal.
π’ BUYBACK β 1138 COSCO SHIPPING Energy Transportation (H Shares) β BlackRock, curr 7.66% (decreased by 0.96pp from prior filing)
Read: Buyback-driven share-base adjustment moved BlackRock's stake down nearly a full point β watch the buyback pace, not this filing, for the real signal.
π’ BUYBACK β 1772 Ganfeng Lithium (H Shares) β BlackRock, curr 8.78% (decreased by 0.78pp from prior filing)
Read: Another buyback-mechanics reclassification of BlackRock's position rather than an active portfolio decision.
π’ BUYBACK β 1787 Shandong Gold Mining (H Shares) β BlackRock, curr 6.38% (decreased by 0.70pp from prior filing)
Read: Issuer buyback activity is the driver here, not BlackRock trimming conviction in the gold miner.
π’ BUYBACK β 268 Kingdee International Software β BlackRock, curr 9.78% (decreased by 0.51pp from prior filing)
Read: Smallest of the five buyback-linked moves today β routine share-base math, no trading implication.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.